Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MEETINGS - Extended newborn screening - anticipating the future (UK) February 2005:

This article was originally published in Clinica

Executive Summary

The UK's Royal Society of Medicine is holding an open meeting on Extended newborn screening - anticipating the future, in London, on February 22 2005. Key topics of the discussion will be the "power of new technologies to extend the scope of neonatal screening", the diseases to which this might be extended and, in particular, issues surrounding screening for cystic fibrosis. For more information and web-based registration, see www.rsm.ac.uk, or contact the RSM on tel: +44 (0)20 7290 2986/2982; fax: +44 (0)20 7290 2989.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT054016

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel